Secondary Logo

Journal Logo

Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus

Levi, F1,2; Randimbison, L1,2; Lucchini, F2; Te, V-C1; La Vecchia, C3,4

European Journal of Cancer Prevention: February 2001 - Volume 10 - Issue 1 - p 91-96
Symposium Proceedings
Free

1 Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, Centre Hospitalier Universitaire Vaudois, Falaises 1, 1011 Lausanne, Switzerland. 2 Unité d’Épidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive Bugnon 17, 1005 Lausanne, Switzerland. 3 Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milano, Italy. 4 Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Via Venezian 1, 20133 Milano, Italy

Correspondence to: F Levi, Registre Vaudois des Tumeurs, CHUV-Falaises 1, 1011 Lausanne, Switzerland. Fax: (+41) 21 323 03 03. E-mail: Fabio.Levi@inst.hospvd.ch

*This paper was an invited presentation of the 18th Annual Symposium of European Cancer Prevention Organisation (ECP): Precancerous lesions of the digestive tract held in Maastricht, The Netherlands, 12–14 October, 2000

Back to Top | Article Outline

Introduction

The incidence of oesophageal adenocarcinoma has been reported to be rising in the United States (Blot et al., 1991, 1993Zheng et al., 1993;Devesa et al., 1998) and in several areas of Europe, including Norway (Hansen et al., 1997), Denmark (Moller, 1992), Sweden (Hansson et al., 1993), the West Midlands and the Oxford area of England (Harrison et al., 1992;Powell and McConkey, 1992), the Swiss Canton of Vaud (Levi et al., 1990a, 1998bLevi and La Vecchia, 1991), as well as in New Zealand (Armstrong and Borman, 1996) and Australia (Thomas et al., 1996;Lord et al., 1998). The upward trends were generally greater in males. Among White males in the US, the incidence of adenocarcinoma of the oesophagus rose by over fourfold between the mid-1970s and the mid-1990s (3.2/100 000 males), surpassing squamous cell cancers in around 1990. The upward trend was greater among older males (Devesa et al., 1998). A similar rise in incidence was observed for adenocarcinoma of the gastric cardia, too, and there are major difficulties and uncertainties in the classification of cancers arising at the gastro-oesophageal junction (Devesa et al., 1998;Jankowski et al., 2000).

However, no clear increase in the incidence of oesophageal adenocarcinoma was observed during the 1980s in males from the three French cancer registries, and some decline was observed for squamous cell cancer in Calvados (Launoy et al., 1994;Desoubeaux et al., 1999), one of the areas with the highest oesophageal rates in France. Other areas showing no clear rise of adenocarcinomas of the oesophagus and gastric cardia in Europe were Basel, Switzerland, Iceland, Bas Rhin, France, southern Ireland and Eindhoven, the Netherlands (Botterweck et al., 2000). The incidence of squamous cell cancer declined in US White males after the mid-1970s, and in Black males after the mid-1980s (Devesa et al., 1998).

The widespread unfavourable trends for oesophageal adenocarcinoma have been related to a number of risk factors which are, at least in part, different from those of squamous cell carcinoma of the oesophagus. Alcohol drinking and tobacco smoking, in fact, account for over 80% of squamous cell oesophageal cancers in developed countries (Negri et al., 1992). While tobacco smoking has been related to the risk of adenocarcinoma of the oesophagus and gastric cancers, too, the association is less strong than for squamous cell carcinomas. Alcohol drinking is not consistently related to the risk of oesophageal adenocarcinoma (Gammon et al., 1997;Zhang et al., 1997). A frequent consumption of vegetables and fruit appears to be related to both squamous cell and adenocarcinoma of the oesophagus (Morris Brown et al., 1995;Levi et al., 2000), whereas overweight and obesity have been consistently related to adeno- but not squamous cell carcinoma of the oesophagus (Morris Brown et al., 1995;Chow et al., 1998). Indeed, measures of body mass index seem to be inversely related to the risk of squamous cell oesophageal cancer (D’Avanzo et al., 1996;Chow et al., 1998). The influence of obesity on adenocarcinoma of the oesophagus and gastric cardia may be related to increased gastro-oesophageal reflux, since the risk of the disease is strongly related to Barrett's oesophagus (Levi et al., 1990b;Gammon et al., 1997). Social class indicators tend to be inversely related to risk of squamous cell and adenocarcinoma of the oesophagus (Gammon et al., 1997;Levi et al., 2000).

In the Swiss Canton of Vaud, we reported a rise in the incidence of oesophageal adenocarcinomas, but not squamous cell cancers, between 1976 and 1994, in the absence of material change for gastric cardia cancers (Levi et al., 1998b). To further monitor these trends, we updated the analysis of the Vaud Cancer Registry dataset, to include cancers registered up to 1998.

Back to Top | Article Outline

Materials and methods

The Vaud Cancer Registry dataset includes data concerning incident cases of malignant neoplasms in the Canton, whose population, according to the 1990 census, was around 602 000 inhabitants (Levi et al., 1992). Information collected by the Registry for oesophageal cancer includes specification of the subsite of origin (ICD-O:T) and morphological type (ICD-O:M;World Health Organization, 1976). The following morphological categories were considered: squamous cell carcinoma (ICD-O:M 8050–8082); adenocarcinoma (8140–8573); and other or unspecified cancers. In 1976–1979, 87% of oesophageal cancers were histologically confirmed; corresponding values for 1994–1998 were 93.3%. The following ICD-O:T codes were considered and grouped into separate anatomical sites: (1) oesophagus: upper and middle third (ICD-O:T: 150.0,1.,3.,4); (2) lower third (150.2,.5); and (3) other or unspecified subsites (150.8,.9).

Age-standardized incidence rates per 100 000 population (world standard) were calculated. Average annual percentage changes in incidence rates were estimated by fitting a log-linear regression model.

Back to Top | Article Outline

Results and comments

Table 1

Table 1

Table 1

gives the distribution of 1123 cases of oesophageal cancer registered in Vaud between 1976 and 1998 according to calendar period, sex, histological type and site of origin. For squamous cell cancer, the trends were inconsistent in both sexes, with no material or significant linear trend in annual change, and some decline in incidence was observed over the last few years. In contrast, the incidence of oesophageal adenocarcinoma rose steadily in males, from 0.5/100 000 at all ages in 1976–1979 to 1.93 in 1995–1998, with an average percentage annual rise of 5.1%. Incidence of oesophageal adenocarcinoma appeared to rise in women, too, although rates remained low (0.12/100 000) (Fig. 1

Fig. 1

Fig. 1

). Thus, the male/female sex ratio in the late 1990s was almost 5 for squamous cell, but over 10 for adenocarcinoma. For males, there was a decline between 1976 and 1990 of other and unspecified oesophageal cancers. With reference to site of origin, no clear pattern of trend was observed over time, and the sex ratio remained around 5 for both upper-middle and lower third of the oesophagus.

Table 2

Table 2

Table 2

gives comparable figures for two separate age groups for males. The rise in adenocarcinoma – as well as the recent decline in squamous cell cancer – was larger or restricted to men aged ≥65 years.

With reference to main recognized risk factors, Table 3

Table 3

Table 3

gives – as an example and for comparative purposes – the multivariate relative risk (RR) of oesophageal adenocarcinoma and of squamous cell cancer from a large multicentre US study (Gammon et al., 1997;Chow et al., 1998) in relation to tobacco, alcohol and body mass index (BMI). The RRs of squamous cell cancer were 7.4 for the highest level of alcohol, 3.9 for tobacco, and 0.6 for BMI. Corresponding values for adenocarcinoma were 0.9, 2.1 and 2.9, respectively (Table 3). In a case–control study conducted in Vaud, Switzerland on 92 cases and 327 controls (Levi et al., 2000), the RRs of oesophageal squamous cell cancer were 96.4 for the highest level of alcohol, 13.0 for tobacco, and 0.15 for BMI, and all the trends in risk were significant (Table 4

Table 4

Table 4

). This confirms that alcohol and tobacco are consistently more strongly related to squamous cell than to adenocarcinoma, while BMI is directly related to adenocarcinoma, but inversely to squamous cell cancer.

This pattern of risk factors is broadly consistent with the descriptive epidemiology of various histological types of oesophageal cancer. The falls in squamous cell cancer, in fact, should be attributed to the recent declines in alcohol and tobacco consumption in males, while the upward trends of adenocarcinomas may reflect the rising prevalence of obesity (Wietlisbach et al., 1997). A role of newer anti-ulcer drugs, including histamin-2 receptor antagonists and proton pump inhibitors on the risk of oesophageal adenocarcinoma has been suggested on the basis of animal data, but epidemiological evidence in humans is at present reassuring (Fioretti et al., 1997;La Vecchia and Tavani, 2000).

The overall age-adjusted incidence of oesophageal adenocarcinoma in males in Vaud (1.8/100 000 in 1995–1998) is higher than reported in northern Europe, but lower than in the US (3.2/100 000 US Whites, US standard;Devesa et al., 1998). The incidence of oesophageal squamous cell cancer, though declining, remains comparatively high, thus contributing to an overall high incidence of oesophageal cancer in Vaud as well as in the French-speaking areas of Switzerland, which is probably related to the persistently high – in comparative terms – alcohol and tobacco consumption in these populations (Levi et al., 1998a).

Back to Top | Article Outline

Acknowledgements—

The contributions of Mrs C. Pasche, of the Vaud Cancer Registry's staff, and of the Swiss and Vaud Leagues against cancer are gratefully acknowledged.

Back to Top | Article Outline

References

1. Armstrong RW , Borman B ( 1996 ). Trends in incidence rates of adenocarcinoma of the esophagus and gastric cardia in New Zealand, 1978–1992 . Int J Epidemiol 25 : 941 – 947 .
2. Blot WJ , Devesa SS , Kneller RW , Fraumeni JF Jr ( 1991 ). Rising incidence of adenocarcinoma of the esophagus and gastric cardia . JAMA 265 : 1287 – 1289 .
3. Blot WJ , Devesa S , Fraumeni JF Jr ( 1993 ). Continuing climb in rates of esophageal adenocarcinoma: an update . JAMA 270 : 1320 .
4. Botterweck AAM , Schouten LJ , Volovics A , Dorant E , van den Brandt PA ( 2000 ). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries . Int J Epidemiol 29 : 645 – 654 .
5. Chow W-H , Blot WJ , Vaughan TL et al. ( 1998 ). Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia . J Natl Cancer Inst 90 : 150 – 155 .
6. D'Avanzo B , La Vecchia C , Talamini R , Franceschi S ( 1996 ). Anthropometric measures and risk of cancer of the upper digestive and respiratory tract . Nutr Cancer 26 : 219 – 227 .
7. Desoubeaux N , Le Prieur A , Launoy G et al. ( 1999 ). Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978–1995: a population based study . Eur J Cancer Prev 8 : 479 – 486 .
8. Devesa SS , Blot WJ , Fraumeni JF Jr ( 1998 ). Changing patterns of the incidence of esophageal and gastric carcinoma in the United States . Cancer 83 : 2049 – 2053 .
9. Fioretti F , Tavani A , La Vecchia C , Franceschi S ( 1997 ). Histamine-2-receptor antagonists and oesophageal cancer . Eur J Cancer Prev 6 : 143 – 146 .
10. Gammon MD , Schoenberg JB , Ahsan H et al. ( 1997 ). Tobacco, alcohol, and socioeconomic status and adenocarcinoma of the esophagus and gastric cardia . J Natl Cancer Inst 89 : 1277 – 1284 .
11. Hansen S , Wiig JN , Giercksky KE , Tretli S ( 1997 ). Esophageal and gastric carcinoma in Norway 1958–1992: incidence time trend variability according to morphological subtypes and organ subsites . Int J Cancer 71 : 340 – 344 .
12. Hansson LE , Sparén P , Nyrén O ( 1993 ). Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985 . Br J Surg 80 : 374 – 377 .
13. Harrison SL , Goldacre MJ , Seagroatt V ( 1992 ). Trends in registered incidence of oesophageal and stomach cancer in the Oxford region, 1974–88 . Eur J Cancer Prev 1 : 271 – 274 .
14. Jankowski JA , Perry I , Harrison RF ( 2000 ). Gastro-oesophageal cancer: death at the junction . BMJ 321 : 463 – 464 .
15. Launoy G , Faivre J , Pienkowski P et al. ( 1994 ). Changing pattern of oesophageal cancer incidence in France . Int J Epidemiol 23 : 246 – 251 .
16. La Vecchia C, Tavani A (2000). Epidemiological studies on cancer in humans in relation to the use of antiulcer drugs. Symposium on Predictive Value of Gastric Neuroendocrine Tumours and Forestomach Tumours in Rodents for Carcinogenic Hazard Identification, 29 November–1 December 1999. IARC, Lyon (in press).
17. Levi C , La Vecchia C ( 1991 ). Adenocarcinoma of the esophagus in Switzerland . JAMA 265 : 2960 .
18. Levi F , La Vecchia C , Te VC ( 1990 ). Descriptive epidemiology of adenocarcinoma of the cardia and distal stomach in the Swiss Canton of Vaud . Tumori 76 : 167 – 171 .
19. Levi F , Ollyo JB , La Vecchia C et al. ( 1990 ). The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus . Int J Cancer 45 : 852 – 854 .
20. Levi F, Te VC, Randimbison L, La Vecchia C, Randriamiharisoa A (1992). Statistics from the Registry of the Canton of Vaud, Switzerland, 1983–87. In Cancer Incidence in Five Continents, Vol VI (eds Parkin DM, Muir CS, Whelan SL, et al.); IARC Scientific Publication No 120. IARC, Lyon, pp. 762–5.
21. Levi F , Lucchini F , Boyle P , Negri E , La Vecchia C ( 1998 ). Cancer incidence and mortality in Europe . J Epidemiol Biostat 3 : 295 – 373 .
22. Levi F , Randimbison L , La Vecchia C ( 1998 ). Esophageal and gastric carcinoma in Vaud, Switzerland, 1967–1994 . Int J Cancer 75 : 160 – 161 .
23. Levi F , Pasche C , Luccchini F et al. ( 2000 ). Food groups and oesophageal cancer risk in Vaud, Switzerland . Eur J Cancer Prev 9 : 257 – 263 .
24. Lord RV , Law MG , Ward RL et al. ( 1998 ). Rising incidence of oesophageal adenocarcinoma in men in Australia . J Gastroenterol Hepatol 13 : 356 – 362 .
25. Moller H ( 1992 ). Incidence of cancer of esophagus, cardia and stomach in Denmark . Eur J Cancer Prev 1 : 159 – 164 .
26. Morris Brown L , Swanson CA , Gridley G et al. ( 1995 ). Adenocarcinoma of the esophagus: role of obesity and diet . J Natl Cancer Inst 87 : 104 – 109 .
27. Negri E , La Vecchia C , Franceschi S , Decarli A , Bruzzi P ( 1992 ). Attributable risks for oesophageal cancer in Northern Italy . Eur J Cancer 28A : 1167 – 1171 .
28. Powell J , McConkey CC ( 1992 ). The rising trend in oesophageal adenocarcinoma and gastric cardia . Eur J Cancer Prev 1 : 265 – 269 .
29. Thomas RJ , Lade S , Giles GG , Thursfield V ( 1996 ). Incidence trends in oesophageal and proximal gastric carcinoma in Victoria . Aust N Z J Surg 66 : 271 – 275 .
30. Wietlisbach V , Paccaud F , Rickenbach M , Gutzwiller F ( 1997 ). Trends in cardiovascular risk factors (1984–1993) in a Swiss region: results of three population surveys . Prev Med 26 : 523 – 533 .
31. World Health Organization. ( 1976 ). International Classification of Diseases for Oncology WHO , Geneva .
32. Zhang Z-F , Kurtz RC , Marshall JR ( 1997 ). Cigarette smoking and esophageal and gastric cardia adenocarcinoma . J Natl Cancer Inst 89 : 1247 – 1249 .
33. Zheng T , Mayne ST , Holford TR et al. ( 1993 ). The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955–1989 . Cancer 72 : 330 – 340 .
Keywords:

Adenocarcinoma; incidence; neoplasms; oesophagus; risk factors; squamous cell carcinoma; time trends.

© 2001 Lippincott Williams & Wilkins, Inc.